| 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus A Fanouriakis, M Kostopoulou, A Alunno, M Aringer, I Bajema, JN Boletis, ... Annals of the rheumatic diseases 78 (6), 736-745, 2019 | 1770 | 2019 |
| 2019 update of the joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA–EDTA) recommendations for the … A Fanouriakis, M Kostopoulou, K Cheema, HJ Anders, M Aringer, ... Annals of the rheumatic diseases 79 (6), 713-723, 2020 | 677 | 2020 |
| Update οn the diagnosis and management of systemic lupus erythematosus A Fanouriakis, N Tziolos, G Bertsias, DT Boumpas Annals of the rheumatic diseases 80 (1), 14-25, 2021 | 477 | 2021 |
| Diagnostic criteria for systemic lupus erythematosus: has the time come? GK Bertsias, C Pamfil, A Fanouriakis, DT Boumpas Nature Reviews Rheumatology 9 (11), 687-694, 2013 | 167 | 2013 |
| Pathogenic and therapeutic relevance of JAK/STAT signaling in systemic lupus erythematosus: integration of distinct inflammatory pathways and the prospect of their inhibition … A Alunno, I Padjen, A Fanouriakis, DT Boumpas Cells 8 (8), 898, 2019 | 135 | 2019 |
| Epidemiology and burden of systemic lupus erythematosus in a Southern European population: data from the community-based lupus registry of Crete, Greece I Gergianaki, A Fanouriakis, A Repa, M Tzanakakis, C Adamichou, ... Annals of the rheumatic diseases 76 (12), 1992-2000, 2017 | 119 | 2017 |
| Combined genetic and transcriptome analysis of patients with SLE: distinct, targetable signatures for susceptibility and severity NI Panousis, GK Bertsias, H Ongen, I Gergianaki, MG Tektonidou, ... Annals of the rheumatic diseases 78 (8), 1079-1089, 2019 | 109 | 2019 |
| Interleukin-21 is increased in active systemic lupus erythematosus patients and contributes to the generation of plasma B cells M Nakou, ED Papadimitraki, A Fanouriakis, GK Bertsias, C Choulaki, ... Clin Exp Rheumatol 31 (2), 172-179, 2013 | 98 | 2013 |
| In an early SLE cohort the ACR-1997, SLICC-2012 and EULAR/ACR-2019 criteria classify non-overlapping groups of patients: use of all three criteria ensures optimal capture for … C Adamichou, D Nikolopoulos, I Genitsaridi, A Bortoluzzi, A Fanouriakis, ... Annals of the rheumatic diseases 79 (2), 232-241, 2020 | 93 | 2020 |
| EULAR recommendations for the management of systemic lupus erythematosus: 2023 update A Fanouriakis, M Kostopoulou, J Andersen, M Aringer, L Arnaud, SC Bae, ... Annals of the rheumatic diseases 83 (1), 15-29, 2024 | 81 | 2024 |
| Pathogenesis and treatment of CNS lupus A Fanouriakis, DT Boumpas, GK Bertsias Current opinion in rheumatology 25 (5), 577-583, 2013 | 75 | 2013 |
| Low disease activity—irrespective of serologic status at baseline—associated with reduction of corticosteroid dose and number of flares in patients with systemic lupus … A Fanouriakis, C Adamichou, S Koutsoviti, S Panopoulos, C Staveri, ... Seminars in arthritis and rheumatism 48 (3), 467-474, 2018 | 74 | 2018 |
| Lupus or not? SLE Risk Probability Index (SLERPI): a simple, clinician-friendly machine learning-based model to assist the diagnosis of systemic lupus erythematosus C Adamichou, I Genitsaridi, D Nikolopoulos, M Nikoloudaki, A Repa, ... Annals of the rheumatic diseases 80 (6), 758-766, 2021 | 69 | 2021 |
| EULAR recommendations for neuropsychiatric systemic lupus erythematosus vs usual care: results from two European centres C Pamfil, A Fanouriakis, L Damian, M Rinzis, P Sidiropoulos, G Tsivgoulis, ... Rheumatology 54 (7), 1270-1278, 2015 | 69 | 2015 |
| Cyclophosphamide in combination with glucocorticoids for severe neuropsychiatric systemic lupus erythematosus: a retrospective, observational two-centre study A Fanouriakis, C Pamfil, P Sidiropoulos, L Damian, A Flestea, G Gusetu, ... Lupus 25 (6), 627-636, 2016 | 54 | 2016 |
| Management of lupus nephritis: a systematic literature review informing the 2019 update of the joint EULAR and European Renal Association-European Dialysis and Transplant … M Kostopoulou, A Fanouriakis, K Cheema, J Boletis, G Bertsias, D Jayne, ... RMD open 6 (2), e001263, 2020 | 53 | 2020 |
| Neuropsychiatric lupus or not? Cerebral hypoperfusion by perfusion-weighted MRI in normal-appearing white matter in primary neuropsychiatric lupus erythematosus E Papadaki, A Fanouriakis, E Kavroulakis, D Karageorgou, ... Annals of the rheumatic diseases 77 (3), 441-448, 2018 | 52 | 2018 |
| Changing paradigms in the treatment of systemic lupus erythematosus A Fanouriakis, G Bertsias Lupus Science & Medicine 6 (1), e000310, 2019 | 50 | 2019 |
| Canakinumab for recurrent rheumatic disease associated-pericarditis: a case series with long-term follow-up N Kougkas, A Fanouriakis, I Papalopoulos, G Bertsias, N Avgoustidis, ... Rheumatology 57 (8), 1494-1495, 2018 | 49 | 2018 |
| Cerebrovascular events in systemic lupus erythematosus: diagnosis and management D Nikolopoulos, A Fanouriakis, DT Boumpas Mediterranean journal of rheumatology 30 (1), 7-15, 2019 | 48 | 2019 |
